MAPK3 (tGFP-tagged) - Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
Products
MAPK3 (tGFP-tagged) - Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 3
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
Lenti ORF clone of Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 1, Myc-DDK-tagged
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK |
- LentiORF®
Lenti ORF clone of Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 1, mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
Lenti ORF clone of Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 1, Myc-DDK-tagged
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
- LentiORF®
Lenti ORF clone of Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 3, mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
Lenti ORF clone of Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 2, mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
Lenti ORF clone of Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 3, Myc-DDK-tagged
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
- LentiORF®
MAPK3 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Lenti ORF clone of Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 1, mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP |
- LentiORF®
MAPK3 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Lenti ORF clone of Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 2, Myc-DDK-tagged
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
- LentiORF®
MAPK3 (untagged)-Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 1
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-XL5 |
MAPK3 (untagged)-Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 3
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
MAPK3 (untagged)-Human mitogen-activated protein kinase 3 (MAPK3), transcript variant 2
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Reporters
Conjugates
Modifications
Clonalities
Mutants
Assay Types
Brands
QC Levels
Pathways
- Acute myeloid leukemia (51)
- Adherens junction (51)
- Alzheimer's disease (51)
- Axon guidance (51)
- B cell receptor signaling pathway (51)
- Bladder cancer (51)
- Chemokine signaling pathway (51)
- Chronic myeloid leukemia (51)
- Colorectal cancer (51)
- Dorso-ventral axis formation (51)
- Endometrial cancer (51)
- ErbB signaling pathway (51)
- Fc epsilon RI signaling pathway (51)
- Fc gamma R-mediated phagocytosis (51)
- Focal adhesion (51)
- Gap junction (51)
- Glioma (51)
- GnRH signaling pathway (51)
- Insulin signaling pathway (51)
- Long-term depression (51)
- Long-term potentiation (51)
- MAPK signaling pathway (51)
- Melanogenesis (51)
- Melanoma (51)
- NOD-like receptor signaling pathway (51)
- Natural killer cell mediated cytotoxicity (51)
- Neurotrophin signaling pathway (51)
- Non-small cell lung cancer (51)
- Oocyte meiosis (51)
- Pancreatic cancer (51)
- Pathways in cancer (51)
- Prion diseases (51)
- Progesterone-mediated oocyte maturation (51)
- Prostate cancer (51)
- Regulation of actin cytoskeleton (51)
- Renal cell carcinoma (51)
- T cell receptor signaling pathway (51)
- TGF-beta signaling pathway (51)
- Thyroid cancer (51)
- Toll-like receptor signaling pathway (51)
- Type II diabetes mellitus (51)
- VEGF signaling pathway (51)
- Vascular smooth muscle contraction (51)
- mTOR signaling pathway (51)
